Haafor (Singapore)’s Amicus Therapeutics FOLD Stock Holding History

Haafor (Singapore)’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,609	Closed	-$133K	–	266
2019 Q4	$133K	Buy	+13,609	New	+$125K	0.09%	252

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Haafor (Singapore)'s FOLD Position: Q1 2020 in Review

Haafor (Singapore) sold out of Amicus Therapeutics (FOLD) in Q1 2020, closing a stake of 13,609 shares — an estimated $133K sold.

Haafor (Singapore) first reported a position in FOLD in Q4 2019 and held it in 1 quarter. The position peaked at $133K in Q4 2019. 203 funds tracked by Wall St. Rank hold FOLD as of Q1 2020.

Haafor (Singapore) reported no remaining Amicus Therapeutics position as of Q1 2020 after selling out during the quarter.
Haafor (Singapore) sold 13,609 Amicus Therapeutics shares in Q1 2020, an estimated $133K.
Haafor (Singapore) first reported a position in Amicus Therapeutics in Q4 2019 and held it in 1 quarter.
Haafor (Singapore)'s Amicus Therapeutics position peaked at $133K in Q4 2019.
203 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2020.

Based on Haafor (Singapore)'s 13F filing for Q1 2020, filed 13 May 2020.